Maintenance Lenalidomide in Lymphoma
Clinical trial NCT01575860 · COMPLETED
Trial details
- NCT number
- NCT01575860
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2018-05-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.